How to calculate indirect costs in economic evaluations

W. B.F. Brouwer*, M. A. Koopmanschap

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

10 Citations (Scopus)
1 Downloads (Pure)

Abstract

In a recent issue of PharmacoEconomics, Liljas discusses how to incorporate indirect costs into a cost-effectiveness analysis. He argues that the human capital–cost approach is the best available method for estimating productivity losses due to illness from a societal perspective rather than the friction-cost approach or the quality-adjusted life-year (QALY) approach as advocated by the US Panel on Cost-Effectiveness in Health and Medicine. However, although Liljas raises interesting issues, we feel that the incorporation of indirect costs estimated with the human capital–cost approach is not recommendable, especially for longer absence spells. [...]
Original languageEnglish
Pages (from-to)563-566
Number of pages4
JournalPharmacoEconomics
Volume13
Issue number5
DOIs
Publication statusPublished - May 1998

Fingerprint

Dive into the research topics of 'How to calculate indirect costs in economic evaluations'. Together they form a unique fingerprint.

Cite this